Genome-Editing and Biomedical Cell Products: Current State, Safety and Efficacy
Advances in ex vivo technologies of human genome editing have made it possible to develop new approaches to the treatment of genetic, oncological, infectious and other diseases, which may involve the use of biomedical cell products. However, despite the rapid development of these technologies and a...
Saved in:
| Main Authors: | A. A. Goryaev, M. V. Savkina, K. M. Mefed, V. P. Bondarev, V. A. Merkulov, V. V. Tarasov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-09-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/169 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GENE-CELL THERAPY OF HIV AND HEMATOLOGICAL MALIGNANCES BASED ON HEMATOPOIETIC STEM CELL TRANSPLANTATION AND SITE-SPECIFIC GENOME EDITING
by: M. О. Popova, et al.
Published: (2017-04-01) -
Genome editing in grain legumes for food security
by: Joshua Yeboah Asiamah, et al.
Published: (2025-05-01) -
The Current Use of Biomedical Cell Products for Cancer Treatment
by: E. A. Ustyugova, et al.
Published: (2019-12-01) -
Methods of yeast genome editing
by: A. S. Rozanov, et al.
Published: (2018-01-01) -
CRISPR/Cas9 Mediated Genome Editing in Crop Plants
by: Abdulrezzak Memon
Published: (2021-12-01)